Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously
- COVID-19
- Seasonal Influenza
Jun 14, 2021
Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate
- COVID-19
- Seasonal Influenza
May 10, 2021
Novavax Appoints Leadership Team to Advance NanoFlu through Regulatory Licensure
- Seasonal Influenza
Oct 13, 2020
Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
- Seasonal Influenza
Mar 24, 2020
Novavax’ Preclinical NanoFlu Data Published in Vaccines; Details Structural Basis for Broadly Neutralizing Immunity
- Seasonal Influenza
Feb 25, 2020

Show per page